The Role of Inflammatory Parameters and Antibody Seroconversion on COVID-19 Outcomes in Patients with Central Obesity

• Published in: Acta medica Indonesiana Vol. 56; no. 4; p. 483
• Main Authors: Wafa, Syahidatul, Tahapary, Dicky Levenus, Yunihastuti, Evy, Wibowo, Heri, Rumende, Cleopas Martin, Harimurti, Kuntjoro, Suastika, Ketut, Kurniawan, Farid, Kartika, Rona, Pradnjaparamita, Tika, Harbuwono, Dante Saksono
• Format: Journal Article
• Language: English
• Published: Indonesia Interna Publishing 01.10.2024
• Subjects: Adult; Aged; Antibodies, Viral - blood; antibody response; central obesity; Cohort Studies; COVID-19 - blood; COVID-19 - complications; COVID-19 - epidemiology; COVID-19 - immunology; covid-19 severity; Cytokines - blood; Female; Hospitalization; Humans; Indonesia - epidemiology; Inflammation; inflammatory parameters; Male; Middle Aged; Obesity, Abdominal - blood; Obesity, Abdominal - complications; Obesity, Abdominal - epidemiology; Obesity, Abdominal - immunology; poor outcome; Risk Factors; SARS-CoV-2 - immunology; Seroconversion; Indonesia; poor outcome; central obesity; COVID-19 severity; inflammatory parameters; antibody response

Central obesity increases the risk of developing poor outcomes of COVID-19. The pro-inflammatory state and antibody dysfunction are thought to contribute to poor outcomes; however, the evidence is unclear. This is a cohort study among COVID-19 patients with central obesity in Dr. Cipto Mangunkusumo...